Detalhe da pesquisa
1.
Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: Retrospective analysis of an electronic health records database in the United States.
J Am Acad Dermatol
; 86(4): 748-757, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547358
2.
Disease burden and predictors associated with non-response to antihistamine-based therapy in chronic spontaneous urticaria.
World Allergy Organ J
; 16(12): 100843, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38075554
3.
Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US Claims Database.
Dermatol Ther (Heidelb)
; 13(11): 2635-2648, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726542
4.
Impact of secukinumab on patient-reported outcomes in biologic-naive patients with psoriasis in a US real-world setting.
J Dermatolog Treat
; 33(8): 3178-3187, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36026543
5.
Perspectives on nonmedical switching and the COVID-19 pandemic: a narrative review.
Am J Manag Care
; 28(11): e417-e425, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36374660
6.
Utilization Trends and Impact of Secukinumab Treatment on Clinical Outcomes in Biologic-Naive Patients with Psoriasis in a US Real-World Setting.
Dermatol Ther (Heidelb)
; 12(6): 1351-1365, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35551619
7.
Correlation Between Change in Psoriasis Area and Severity Index and Dermatology Life Quality Index in Patients with Psoriasis: Pooled Analysis from Four Phase 3 Clinical Trials of Secukinumab.
Dermatol Ther (Heidelb)
; 11(4): 1373-1384, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34110605
8.
Real-World Satisfaction with Secukinumab in Clearing the Skin of Patients with Plaque Psoriasis through 24 Months of Follow-Up: Results from US Dermatology Electronic Medical Records.
Dermatol Ther (Heidelb)
; 11(5): 1733-1749, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34455554
9.
Comparison of infection-related hospitalization risk and costs in tumor necrosis factor inhibitor-experienced patients with rheumatoid arthritis (RA) treated with abatacept or other targeted disease-modifying anti-rheumatic drugs (tDMARDs).
J Med Econ
; 23(9): 1025-1031, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32427547
10.
Factors affecting the adoption and use of gene expression profiling by oncologists in clinical practice.
Per Med
; 12(1): 33-42, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29767541